Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

P15813 (CD1D_HUMAN) Homo sapiens (Human)

Antigen-presenting glycoprotein CD1d UniProtKBInterProSTRINGInteractive Modelling

335 aa; Sequence (Fasta)

Available Structures

19 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of human TCR Alpha Chain-TRAV21-TRAJ8, Beta Chain-TRBV7-8, Antigen-presenting gly… Heteromer
A0A0B4J279; A0A5B9; P01848; P61769;
21-295
NAG;JLS;
Assess
Human CD1d presenting sphingomyelin C24:1 in complex with VHH nanobody 1D17 Heteromer
P61769;
23-296
FO4;NAG;
Assess
Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22 Heteromer
P61769;
23-296
NAG;NAG;NAG;AGH;PEG;CL;SO4;BGC;
Assess
Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5 Heteromer
P61769;
23-295
NAG;NAG;NAG;SO4;AGH;CL;
Assess
Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and V… Heteromer
A0A0B4J240; K7N5M3; K7N5M4; P61769;
24-296
NAG;AGH;
Assess
Crystal structure of human CD1d-alpha-Galactosylceramide in complex with semi-invariant NKT cell re… Heteromer
P61769;
24-295
NAG;NAG;AGH;MG;
Assess
Crystal structure of human CD1d-lysophosphatidylcholine Heteromer
P61769;
24-295
NAG;LSC;HEX;SO4;GOL;UND;
Assess
Crystal Structure of 9C2 TCR bound to CD1d Heteromer
P0CF51; P61769; Q6PJ56;
24-295
NAG;NAG;NAG;BMA;MG;JLS;CL;
Assess
The crystal structure of human CD1d with and without alpha-Galactosylceramide Heteromer
P61769;
24-295
AGH;
Assess
Crystal structure of human autoreactive-Valpha24 NKT TCR in complex with CD1d-beta-galactosylcerami… Heteromer
P01848; P61769;
24-295
GCY;
Assess
Crystal structure of CD1d-lipid-antigen complexed with Beta-2-Microglobulin, NKT15 Alpha-Chain and … Heteromer
P01848; P61769;
24-295
NAG;NAG;AGH;
Assess
The molecular bases of Delta/Alpha beta T cell-mediated antigen recognition. Heteromer
P61769;
25-295
NAG;NAG;NAG;JLS;
Assess
Ternary crystal structure of the human NKT TCR-CD1d-4'deoxy-alpha-galactosylceramide complex Heteromer
P61769;
25-295
NAG;4GH;MG;
Assess
Crystal structure of a human Valpha24(-) NKT TCR in complex with CD1d/alpha-galactosylceramide Heteromer
K7N5M3; K7N5M4; P61769;
26-295
NAG;AGH;FUC;GOL;
Assess
Crystal structure of an iNKT TCR in complex with CD1d-lysophosphatidylcholine Heteromer
P61769;
26-295
NAG;LSC;HEX;D12;GOL;
Assess
Ternary crystal structure of the human NKT TCR-CD1d-C20:2 complex Heteromer
P61769;
26-295
NAG;DB3;MG;
Assess
Crystal structure of human TCR Alpha Chain-TRAV12-3, Beta Chain-TRBV6-5, Antigen-presenting molecul… Heteromer
A0A0B4J271; A0A0K0K1A5; A0A5B9; P01848; P61769;
26-295
NAG;JLS;
Assess
Structure of human CD1d-sulfatide Heteromer
P01887; P11609;
24-202
NAG;CIS;
Assess
Structure of the DP10.7 TCR with CD1d-sulfatide Heteromer
P01887; P11609; Q6PJ56;
24-202
NAG;CIS;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4mng.1.Bmonomer0.8524-295
NAG;92.36
Assess